Matsunaga K, Morita I, Oguchi Y, Fujii T, Yoshikumi C, Nomoto K
Gan To Kagaku Ryoho. 1986 Dec;13(12):3468-75.
PSK is a protein-bound polysaccharide prepared from cultured mycelium of the Basidiomycete Coriolus versicolor. Effects of PSK on the immunologic responsiveness in tumor-bearing animals were investigated using syngeneic or allogeneic tumors in mice (Lewis lung carcinoma, B16 melanoma, Meth A fibrosarcoma, adenocarcinoma 755, X5563 plasmacytoma, colon 26, MOPC 31C myeloma, sarcoma 180 and Ehrlich carcinoma), rats (BC47 bladder carcinoma, Walker 256 sarcoma and AH7974 hepatoma), hamsters (HA-1T tumor and RPMI 1846 melanoma), guinea pigs (line-10 hepatoma) and rabbit (VX2 and VX7 tumor). Oral or intraperitoneal administration of PSK restored the depressed delayed hypersensitivity against sheep erythrocytes to a normal level in these tumor-host systems. Also, oral administration of PSK lowered the activity of immunosuppressive substances in the serum of tumor-bearing animals. These results suggest that PSK exhibits antitumor effects by restoring the depressed immunologic responsiveness in tumor-bearing animals.
PSK是一种从担子菌云芝培养菌丝体中制备的蛋白结合多糖。使用小鼠(Lewis肺癌、B16黑色素瘤、Meth A纤维肉瘤、腺癌755、X5563浆细胞瘤、结肠癌26、MOPC 31C骨髓瘤、肉瘤180和艾氏癌)、大鼠(BC47膀胱癌、Walker 256肉瘤和AH7974肝癌)、仓鼠(HA-1T肿瘤和RPMI 1846黑色素瘤)、豚鼠(10号线肝癌)和兔子(VX2和VX7肿瘤)的同基因或异基因肿瘤,研究了PSK对荷瘤动物免疫反应性的影响。在这些肿瘤宿主系统中,口服或腹腔注射PSK可将针对绵羊红细胞的迟发型超敏反应恢复到正常水平。此外,口服PSK可降低荷瘤动物血清中免疫抑制物质的活性。这些结果表明,PSK通过恢复荷瘤动物中降低的免疫反应性来发挥抗肿瘤作用。